Interpatient variability in tamoxifen respone among breast cancer patient: the use of pharmacogenetics and metabolomics in closing the gaps in clinical practice / Nor Izwani Mohamed
Tamoxifen has been widely used as the standard adjuvant therapy for breast cancer patients with oestrogen receptor-positive status, especially in the highrisk pre- and postmenopausal women. However, 30 to 50% of ER-positive breast cancer patients do not respond to tamoxifen therapy. Major challenges...
| Main Author: | |
|---|---|
| Format: | Book Section |
| Language: | English |
| Published: |
Institute of Graduate Studies, UiTM
2017
|
| Subjects: | |
| Online Access: | http://ir.uitm.edu.my/id/eprint/19903/ http://ir.uitm.edu.my/id/eprint/19903/1/ABS_NOR%20IZWANI%20MOHAMED%20TDRA%20VOL%2012%20IGS%2017.pdf |